General Information of DTT (ID: TTR9XHZ)

DTT Name Transforming growth factor beta 1 (TGFB1) DTT Info
Gene Name TGFB1

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Discontinued Drug(s)
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
1 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Pirfenidone DM6VZFQ Idiopathic pulmonary fibrosis CB03.4 Approved [1]
------------------------------------------------------------------------------------
7 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
A435 DMJCL7X Aggressive cancer 2A00-2F9Z IND submitted [2]
TG-C DMLCXPD Arthritis FA20 Phase 3 [3]
LY2157299 DMP8HW1 Arteriosclerosis BD40 Phase 2/3 [4]
Disitertide DM2QBDS Macular degeneration 9B78.3 Phase 2 [5]
ABBV-151 DMIQXDJ Solid tumour/cancer 2A00-2F9Z Phase 1 [6]
ACE-1334 DMF1OUP Systemic sclerosis 4A42 Phase 1 [7]
SRK-181 DM0EWMT Solid tumour/cancer 2A00-2F9Z Phase 1 [8]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Clinical Trial Drug(s)
1 Discontinued Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Mannose phosphate DM1LM7D Lesion 8A00-8C12 Discontinued in Phase 2 [9]
------------------------------------------------------------------------------------
1 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
ART-144 DMEVT4I Osteoarthritis FA00-FA05 Investigative [10]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
2 Clinical pipeline report, company report or official report of Klus Pharma
3 Clinical pipeline report, company report or official report of Tissue Gene, Inc.
4 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
5 Perspectives of TGF-beta inhibition in pancreatic and hepatocellular carcinomas. Oncotarget. 2014 January; 5(1): 78-94.
6 Clinical pipeline report, company report or official report of AbbVie.
7 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2023. Adis Insight
8 Clinical pipeline report, company report or official report of Scholar Rock.
9 The mannose-6-phosphate analogue, PXS64, inhibits fibrosis via TGF-beta1 pathway in human lung fibroblasts. Immunol Lett. 2015 Jun;165(2):90-101.
10 Pharmaceutical products of TORREYA partners. December 2011.